Cyclic amide derivatives

Details Cyclic amide derivatives Cyclic amide derivatives

2007-01-23

2007-01-23

Chang, Celia (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S326000, C546S140000, C546S141000, C546S148000, C546S157000, C546S158000, C546S165000, C546S187000, C546S198000, C546S200000, C546S201000

Reexamination Certificate

active

10220359

ABSTRACT:
Novel compounds represented by the following formula (I) that act as a ligand to sigma receptor/binding cite and a medicament comprising the same as an active ingredient:wherein X represents an alkyl group, an aryl group, a heterocyclic group or the like; Q represents a group represented by —CH2—, —CO—, —O—, —CH(OR7)— or the like wherein R7represents a hydrogen atom, an alkyl group or the like; n represents an integer of from 0 to 5; R1and R2each represent a hydrogen atom, an alkyl group or the like; B represents either of the following groups:wherein R3, R4, R5, and R6each represent a hydrogen atom, a halogen atom, an alkoxyl group or the like; m represents 1 or 2; and the ring of:represents an aromatic heterocyclic ring.

REFERENCES:
patent: 3742951 (1973-07-01), Zaffaroni
patent: 3797494 (1974-03-01), Zaffaroni
patent: 3921636 (1975-11-01), Zaffaroni
patent: 3947578 (1976-03-01), Derible et al.
patent: 3996934 (1976-12-01), Zaffaroni
patent: 4000287 (1976-12-01), Werner
patent: 4031894 (1977-06-01), Urquhart et al.
patent: 4062953 (1977-12-01), Wade et al.
patent: 4168315 (1979-09-01), Rynbrandt et al.
patent: 4495194 (1985-01-01), Dolak et al.
patent: 4762842 (1988-08-01), Cohen et al.
patent: 4783471 (1988-11-01), Carr et al.
patent: 4812461 (1989-03-01), Antoku et al.
patent: 4877798 (1989-10-01), Sorensen
patent: 4908369 (1990-03-01), Schechter et al.
patent: 4908372 (1990-03-01), Carr et al.
patent: 4912117 (1990-03-01), Carr et al.
patent: 4948799 (1990-08-01), Antoku et al.
patent: 4988711 (1991-01-01), Angerbauer et al.
patent: 5001134 (1991-03-01), Ferrand et al.
patent: 5021428 (1991-06-01), Carr et al.
patent: 5093341 (1992-03-01), Carr et al.
patent: 5106855 (1992-04-01), McLees
patent: 5134149 (1992-07-01), Carr et al.
patent: 5141930 (1992-08-01), Nakao et al.
patent: 5166211 (1992-11-01), Carr et al.
patent: 5169096 (1992-12-01), Carr et al.
patent: 5182399 (1993-01-01), Kane
patent: 5231099 (1993-07-01), Cook
patent: 5286866 (1994-02-01), Carr et al.
patent: 5292752 (1994-03-01), Carr et al.
patent: 5356906 (1994-10-01), Ciganek et al.
patent: 5371093 (1994-12-01), Carr et al.
patent: 5380731 (1995-01-01), Carr et al.
patent: 5480892 (1996-01-01), Ciganek et al.
patent: P8705398 (1987-09-01), None
patent: WO 91/06297 (1991-05-01), None
patent: WO 92/18127 (1992-10-01), None
patent: WO 93/22310 (1993-11-01), None
patent: WO 98 31800 (1998-07-01), None
patent: WO 00 48203 (2000-08-01), None
patent: WO 00 55332 (2000-09-01), None
Yamabe et al., “Preparation of cyclic amide . . . ” CA 135:226879 (2001).
Database EMBL 'Online!, Jun. 28, 1999, T. Arakawa, et al., AV169321 XP002199699.
Database EMBL 'Online!, Feb. 20, 1997, M. Marra, et al., “The WahU-HHMI mouse EST project”, AA222797 XP002199700.
A. Bosserhoff, et al., “Mouse CD-RAP/MIA gene Structure, chromosomal localization, and expression in cartilage and chondrosarcoma.”, Developmental Dynamics, vol 208, No. 4, 1997, pp. 516-525, XP001080394 ISSN: 1058-8388.
U.H. Dietz, et al., “Cloning of a retinoic acid-sensitive mRNA expressed in cartilage and during chondrogenesis.”, Journal of Biological Chemistry, vol. 271, No. 6, 1996, pp. 3311-3316, XP001079161 ISSN: 0021-9258.
PCT/US 93/02771 International Search Report.
Frank, et al., “A Systematic Evaluation of the Properties of Self-Stimulation Train-Duration Response Functions”, 1987, vol. 101, No. 4, 546-559.
Carbo, et al., “Differential inhibitory effects of a 5-HT3antagonist on drug-induced stimulation of dopamine release”, European Journal of Pharmacology, 164 (1989) 515-519.
Bozarth, et al., “Involvement of the Ventral Tegmental Dopamine System in Opioid and Psychomotor Stimulant Reinforcement”, NIDA Res Monogr 67: 190-6, 1986.
Golino, et al., “Divergent Effects of Serotonin on Coronary-Artery Dimensions and Blood Flow in Patients with Coronary Atherosclerosis and Control Patients”, The New England Journal of Medicine, Mar. 7, 1991, vol. 324, No. 641-648.
Peroutka, et al., “Multiple Serotonin Receptors: Differential Binding of [3H]5-Hydroxythyptamine, [3H] Lysergic Acid Diethylamide and [3H] Spiroperidol”, Molecular Pharmacology, 16, 687-699.
Di Chiara, et al., “Opposite Effects of Mu and Kappa Opiate Agonists on Dopamine Release in the Nucleus Accumbens and in the Dorsal Caudate of Freely Moving Rats1”, The Journal of Pharmacology and Expermintal Therapeutics, vol. 244, No. 3, 1067-1080.
Schmidt, et al., “5-HT2Antagonists Stereoselectively Prevent the Neurotoxicity of 3,4-Methylenedioxymethamphetamine by Blocking the Acute Stimulation of Dopamine Synthesis: Reversal by L Dopa”, The Journal of Pharmacology and Experimental Therapeutics, (1991), vol. 256, No. 1, 230-235.
Stewart, et al., “Role of Unconditioned and Conditioned Drug Effects in the Self-Administration of Opiates and Stimulants”, Psychological Review, 1984, vol. 91, No. 2, 251-268.
Fibiger, et al., “Mesocorticolimbic Dopamine Systems and Reward”, Ann NY Acad Sci 537:206-15, 1988.
Chemical Abstracts, The American Chemical Society, vol. 105, No. 5, Aug. 4, 1986.
Bush, et al., “The Role of the Endothelium in Arterial Thrombosis and the Influence of Antithrombotic Therapy”, Drug Development Research 7:319-340 (1986).

Affiliated with

Also associated with

Rating

Cyclic amide derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclic amide derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic amide derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3782159